Evidence map›Paper›PMID 34003059›Full record

Observational studyRadiology2021

Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.

Janie M Lee, Laura E Ichikawa, Karen J Wernli, Erin Bowles, Jennifer M Specht, Karla Kerlikowske, Diana L Miglioretti, Kathryn P Lowry, Anna N A Tosteson, Natasha K Stout and 3 more

Open access · greenAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Surveillance mammography in older women-should we press on?Journal of the National Cancer Institute · 2026
    Article
  3. Patient and Physician Perspectives on Using Risk Prediction to Support Breast Cancer Surveillance Decision Making.Medical decision making : an international journal of the Society for Medical Decision Making · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Sources of Disparities in Surveillance Mammography Performance and Risk-Guided Recommendations for Supplemental Breast Imaging: A Simulation Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  14. Article
  15. Contrast enhanced mammography in breast cancer surveillance.Breast cancer research and treatment · 2023
    Article
  16. Article
  17. Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Janie M LeeFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0002-6452-8168
Laura E IchikawaFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0002-0882-6662
Karen J WernliFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0001-7945-0327
Erin BowlesFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0001-6287-7391
Jennifer M SpechtFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).
Karla KerlikowskeFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0001-8793-8779
Diana L MigliorettiFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0002-5547-1833
Kathryn P LowryFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0002-0840-7855
Anna N A TostesonFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0001-7718-8943
Natasha K StoutFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0002-7946-5649
Nehmat HoussamiFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0002-3641-952X
Tracy OnegaFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).
Diana S M BuistFrom the Departments of Radiology (J.M.L., K.P.L.) and Medicine (J.M.S.), University of Washington School of Medicine, Seattle, Wash; Seattle Cancer Care Alliance, 1144 Eastlake Ave East, LG2-200, Seattle, WA 98109 (J.M.L., J.M.S., K.P.L.); Kaiser Permanente Washington Health Research Institute, Seattle, Wash (L.E.I., K.J.W., E.B., D.L.M., D.S.M.B.); Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif (K.J.W., D.S.M.B.); Department of Medicine, Division of General Internal Medicine, Department of Veterans Affairs, and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif (K.K.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis School of Medicine, Davis, Calif (D.L.M.); Dartmouth Institute for Health Policy and Clinical Practice (A.N.A.T., T.O.) and Norris Cotton Cancer Center (A.N.A.T.), Geisel School of Medicine, Dartmouth College, Lebanon, NH; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, Mass (N.K.S.); Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, New South Wales, Australia (N.H.); and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (T.O.).ORCID 0000-0001-5408-2804
Dartmouth College · USSeattle Cancer Care Alliance · USThe University of Sydney · AU

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Diana L Miglioretti · 2011 to 2026
$52.9M
Vermont Screening Process Documentation UnitU54CA163303 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L · 2011 to 2017
$6.4M
Group Health Cancer Research Program Research Specialist AwardR50CA211115 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI BOWLES, ERIN JANELLE AIELLO · 2017 to 2021
$919k
NCI NIH HHS P01 CA154292NCI NIH HHS P30 CA023108NCI NIH HHS R50 CA211115NCI NIH HHS U54 CA163303
6 · The paper itself

Abstract

Background Since 2007, digital mammography and digital breast tomosynthesis (DBT) replaced screen-film mammography. Whether these technologic advances have improved diagnostic performance has, to the knowledge of the authors, not yet been established. Purpose To evaluate the performance and outcomes of surveillance mammography (digital mammography and DBT) performed from 2007 to 2016 in women with a personal history of breast cancer and compare with data from 1996 to 2007 and the performance of digital mammography screening benchmarks. Materials and Methods In this observational cohort study, five Breast Cancer Surveillance Consortium registries provided prospectively collected mammography data linked with tumor registry and pathologic outcomes. This study identified asymptomatic women with American Joint Committee on Cancer anatomic stages 0-III primary breast cancer who underwent surveillance mammography from 2007 to 2016. The primary outcome was a second breast cancer diagnosis within 1 year of mammography. Performance measures included the recall rate, cancer detection rate, interval cancer rate, positive predictive value of biopsy recommendation, sensitivity, and specificity. Results Among 32 331 women who underwent 117 971 surveillance mammographic examinations (112 269 digital mammographic examinations and 5702 DBT examinations), the mean age at initial diagnosis was 59 years ± 12 (standard deviation). Of 1418 second breast cancers diagnosed, 998 were surveillance-detected cancers and 420 were interval cancers. The recall rate was 8.8% (10 365 of 117 971; 95% CI: 8.6%, 9.0%), the cancer detection rate was 8.5 per 1000 examinations (998 of 117 971; 95% CI: 8.0, 9.0), the interval cancer rate was 3.6 per 1000 examinations (420 of 117 971; 95% CI: 3.2, 3.9), the positive predictive value of biopsy recommendation was 31.0% (998 of 3220; 95% CI: 29.4%, 32.7%), the sensitivity was 70.4% (998 of 1418; 95% CI: 67.9%, 72.7%), and the specificity was 98.1% (114 331 of 116 553; 95% CI: 98.0%, 98.2%). Compared with previously published studies, interval cancer rate was comparable with rates from 1996 to 2007 in women with a personal history of breast cancer and was higher than the published digital mammography screening benchmarks. Conclusion In transitioning from screen-film to digital mammography and digital breast tomosynthesis, surveillance mammography performance demonstrated minimal improvement over time and remained inferior to the performance of screening mammography benchmarks. © RSNA, 2021

Indexed as

AdultAgedBreast NeoplasmsFemaleHumansMammographyMass ScreeningMiddle AgedNeoplasm Recurrence, LocalPopulation SurveillancePredictive Value of TestsProspective StudiesRegistriesSensitivity and SpecificityUnited States

Identifiers

PMID34003059
PMCPMC8328154
OpenAlexW3160843001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.